STAAR Surgical Co
NASDAQ:STAA

Watchlist Manager
STAAR Surgical Co Logo
STAAR Surgical Co
NASDAQ:STAA
Watchlist
Price: 23.54 USD -7.25% Market Closed
Market Cap: 1.2B USD

STAAR Surgical Co
Gross Profit

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

STAAR Surgical Co
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
STAAR Surgical Co
NASDAQ:STAA
Gross Profit
$170.3m
CAGR 3-Years
-8%
CAGR 5-Years
9%
CAGR 10-Years
14%
Haemonetics Corp
NYSE:HAE
Gross Profit
$776.3m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
6%
ICU Medical Inc
NASDAQ:ICUI
Gross Profit
$846.3m
CAGR 3-Years
9%
CAGR 5-Years
13%
CAGR 10-Years
17%
Align Technology Inc
NASDAQ:ALGN
Gross Profit
$2.8B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
16%
Lantheus Holdings Inc
NASDAQ:LNTH
Gross Profit
$949.6m
CAGR 3-Years
26%
CAGR 5-Years
44%
CAGR 10-Years
22%
Merit Medical Systems Inc
NASDAQ:MMSI
Gross Profit
$715.9m
CAGR 3-Years
12%
CAGR 5-Years
12%
CAGR 10-Years
12%
No Stocks Found

STAAR Surgical Co
Glance View

Market Cap
1.2B USD
Industry
Health Care

In the early throes of medical innovation, STAAR Surgical Co. carved a niche within the ophthalmic industry, where its focus on implantable lenses set it apart from many contemporaries. Based in Monrovia, California, the company began its journey by enhancing an integral component of human life: vision. Through the skillful development and manufacture of implantable collamer lenses (ICLs), STAAR Surgical has thrived by providing solutions for those seeking alternatives to laser-based surgeries. Its ICL technology directly targets issues like myopia (nearsightedness) and astigmatism, offering patients a reversible, less invasive option than traditional corrective procedures. STAAR Surgical's business model hinges on a blend of specialized technology and strategic market penetration. The company primarily generates revenue by selling its suite of implantable lenses to healthcare providers and clinics worldwide, capitalizing on the rising trend of elective vision correction procedures. With its innovation-driven credo, STAAR continually invests in R&D to enhance its product offerings, ensuring it remains at the forefront of eye-care technology. By targeting emerging markets and expanding its global footprint, particularly in regions with growing demand for premium vision solutions, STAAR has positioned its unique value proposition to capitalize on both technological advancements and changing patient preferences. Through this deliberate strategy, STAAR not only bolsters its revenue streams but also fortifies its presence as a key player in the ophthalmic landscape.

STAA Intrinsic Value
HIDDEN
Show

See Also

What is STAAR Surgical Co's Gross Profit?
Gross Profit
170.3m USD

Based on the financial report for Sep 26, 2025, STAAR Surgical Co's Gross Profit amounts to 170.3m USD.

What is STAAR Surgical Co's Gross Profit growth rate?
Gross Profit CAGR 10Y
14%

Over the last year, the Gross Profit growth was -37%. The average annual Gross Profit growth rates for STAAR Surgical Co have been -8% over the past three years , 9% over the past five years , and 14% over the past ten years .

Back to Top